Squarepoint’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-24,300
Closed -$337K – 5232
2024
Q4
$337K Buy
+24,300
New +$383K ﹤0.01% 4067

Other funds holding PRTA

Squarepoint's PRTA Position: Q2 2026 in Review

Squarepoint reduced its Prothena Corp (PRTA) stake by 3% in Q2 2026, selling an estimated $68.6K and leaving 223,971 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

Squarepoint first reported a position in PRTA in Q4 2015 and has held it in 24 quarters since. The position peaked at $3.8M in Q1 2023. 187 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Squarepoint held 223,971 shares of Prothena Corp worth $2.19M as of Q2 2026.
  • Squarepoint sold 6,949 Prothena Corp shares in Q2 2026, an estimated $68.6K.
  • Prothena Corp made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2270 holding.
  • Squarepoint first reported a position in Prothena Corp in Q4 2015 and has held it in 24 quarters since.
  • Squarepoint's Prothena Corp position peaked at $3.8M in Q1 2023.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.